Company intelligence / Profile preview

Jangho Group

Ownership: Private
Employees: ~10231
Development stage: Other

Overview

Jangho Group operates a large chain of ophthalmology hospitals in Australia providing advanced eye care treatments such as cataract surgery, corneal transplant surgery, retinal surgery, intravitreal injection therapy, laser therapy and other clinical procedures. The group is also one of China’s largest building decoration companies with global operations.

Therapeutic areas: Ophthalmology
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Jangho Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jangho Group.

Explore the full profile